Search details
1.
Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs.
Int J Cancer
; 152(10): 2153-2165, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-36705298
2.
Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation.
PLoS Biol
; 17(11): e3000531, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31682603
3.
A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.
Hepatology
; 72(1): 213-229, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31750554
4.
A4 Pulley Reconstruction Using the Superficialis Oblique Flap and the Transverse Double Loop Techniques: A Biomechanical Evaluation Using a Chicken Model.
Ann Plast Surg
; 87(6): 650-656, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34270466
5.
Dickkopf-1 Inhibition Reactivates Wnt/ß-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
Int J Mol Sci
; 22(23)2021 Nov 29.
Article
in English
| MEDLINE | ID: mdl-34884726
6.
Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells.
Nanomedicine
; 24: 102106, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31666201
7.
Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.
Br J Cancer
; 118(1): 106-116, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29206819
8.
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.
J Biol Chem
; 289(36): 25306-16, 2014 Sep 05.
Article
in English
| MEDLINE | ID: mdl-25037223
9.
Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
Nanomedicine
; 11(8): 1883-92, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26238079
10.
Brush border myosin Ia has tumor suppressor activity in the intestine.
Proc Natl Acad Sci U S A
; 109(5): 1530-5, 2012 Jan 31.
Article
in English
| MEDLINE | ID: mdl-22307608
11.
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
Nat Genet
; 38(5): 566-9, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16642021
12.
RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis.
iScience
; 27(4): 109400, 2024 Apr 19.
Article
in English
| MEDLINE | ID: mdl-38523777
13.
Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.
J Biol Chem
; 287(52): 43472-81, 2012 Dec 21.
Article
in English
| MEDLINE | ID: mdl-23095742
14.
Brush border myosin Ia inactivation in gastric but not endometrial tumors.
Int J Cancer
; 132(8): 1790-9, 2013 Apr 15.
Article
in English
| MEDLINE | ID: mdl-23002058
15.
Villin expression is frequently lost in poorly differentiated colon cancer.
Am J Pathol
; 180(4): 1509-21, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22349300
16.
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds.
Pharmaceutics
; 15(5)2023 May 12.
Article
in English
| MEDLINE | ID: mdl-37242726
17.
Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort.
Pediatr Rheumatol Online J
; 21(1): 64, 2023 Jun 29.
Article
in English
| MEDLINE | ID: mdl-37386568
18.
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.
Adv Sci (Weinh)
; 10(25): e2300299, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37434063
19.
Candidate driver genes in microsatellite-unstable colorectal cancer.
Int J Cancer
; 130(7): 1558-66, 2012 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21544814
20.
Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation.
Eur J Pharm Biopharm
; 171: 39-49, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34998911